“We’re continually trying to make the artificial heart experience better,” SynCardia CEO, Michael Garippa, told Chamber Business News.
PHOENIX, Arizona — Sep. 14, 2018 — Today, heart transplantation is widely recognized as the most effective treatment for advanced and end-stage heart failure patients. Unfortunately, there simply aren’t enough donor hearts to go around.
Emily Richardson from Chamber Business News interviewed SynCardia CEO, Michael Garippa, about the company’s lifesaving solution to this long-standing problem: the SynCardia temporary Total Artificial Heart (TAH).
“We’re continually trying to make the artificial heart experience better,” Garippa explains. “The big innovations are in the power packs. It was originally 400-pounds, and you stayed in the hospital. Then it was 40-pounds, and you stayed in the hospital. Now, there’s a 13-pound unit, called the Freedom Driver, that you can go home with… It works with plug-in power or batteries that let people be untethered, but sooner or later the batteries have to be recharged or the unit gets plugged into the wall.”
Read the full article on Chamber Business News.